← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2023-04-26

Drug application

FDA Application #

ANDA215755

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREGABALIN

Generic name

Pregabalin

Active ingredients

PREGABALIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

STRIDES PHARMA

First approval

2023-04-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown